Quantcast

Posts related to ‘VVUS’

Bull and Bear

Top Analyst Downgrades and Stocks to Sell: Cree, Melco, Monster, VIVUS and More

Investors frequently get to see the analyst upgrades and Buy ratings from Wall Street firms. What investors often do not get to see is when analyst downgrade stocks to sell ...
Read Full Story »
Bull and Bear figures

Closing Bell for Wednesday on Wall Street: Markets Open Lower, Stock Prices Rise All Day

U.S. equity markets opened lower this morning on relatively little economic data. In Europe, Germany reported that industrial production rose 1.2%, while a house price index in the U.K.rose 1.1% ...
Read Full Story »
Bull and Bear figures

Closing Bell for Tuesday on Wall Street: Share Prices Push Indexes to All-Time Highs

U.S. equity markets opened higher this morning following an unexpected 0.25% cut in Australia’s key interest rate to a new level of 2.75%. Japan’s Nikkei reopened today after a two-day ...
Read Full Story »
Pfizer logo

Viagra for Sale Online: Will Other Drug Companies Follow Pfizer?

Yesterday’s announcement by Pfizer Inc. (NYSE: PFE) that it would begin selling its blockbuster Viagra drug online directly to patients is a genuinely ground-breaking deal. The big drug companies like ...
Read Full Story »
pills

Arena Withdraws Application for Weight-Loss Drug Approval in Europe

Drug maker Arena Pharmaceuticals Inc. (NASDAQ: ARNA) has withdrawn its application for European regulatory approval of its weight-loss drug Belviq. The drug was approved for use in the United States ...
Read Full Story »
76764023

Obesity and Weight Loss Drug Shipments Rising

VIVUS Inc. (NASDAQ: VVUS) is the king of weight loss drugs now that it is operating with the first pill to help assist weight loss in a decade. The company's ...
Read Full Story »
biotech

Merrill Lynch Offers Four Key Biotech Drug Updates

Biotech pipeline news and biotech drug news continues to hit. A report from Bank of America/Merrill Lynch is highlighting four small-cap to mid-cap biotech stocks with positive prescription trends so far ...
Read Full Story »
76764023

VIVUS FDA Approval of Qsymia Expands the Obesity Customer Base

VIVUS, Inc. (NASDAQ: VVUS) has just secured Food and Drug Administration  approval of an amendment and modification to the Risk Evaluation and Mitigation Strategy for its weight-loss drug Qsymia. With ...
Read Full Story »
Bull and Bear

13 Must-Read Weekend Stock Stories for Monday

It may be the weekend, and the DJIA hit a new high this last week, but there is no such thing as any rest for the wicked. 24/7 Wall St. ...
Read Full Story »
Bull and Bear figures

24/7 Wall St. Closing Bell — March 6, 2013: Markets Open Higher, Closed Mixed (JCP, ICE, BBY, QCOM, VVUS, GEVO, QIHU, SWHU, PAY, AEO, BIG, TFM, HOV, SPLS, STP, PETS, MTN, CIEN, DANG, JRCC, KR, SFD, MTG, PBR, BBRY)

U.S. equity markets opened higher this morning but struggled to maintain even a flat performance compared to yesterday’s close. Before the markets opened this morning, the Mortgage Bankers Association noted ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades (A, BBY, BFAM, DF, ICE, JCP, MA, QCOM, CRM, SKX, VVUS)

These are some of this Wednesday's top analyst upgrades, downgrades and initiations seen from Wall St. research calls. Agilent Technologies Inc. (NYSE: A) started as Outperform at Leerink Swann. Best Buy ...
Read Full Story »
Wall St Bull statue

Eleven Stocks Expected to Rise by 50% to 100% — or More

Investors are always looking for new ideas. Now that the Dow Jones Industrial Average is trying to hit new highs and investors are pouring record inflows of capital into stocks, ...
Read Full Story »
Bull and Bear figures

24/7 Wall St. Closing Bell — February 26, 2013: Markets Show a Little Enthusiasm (ADM, LULU, SNDK, YUM, IP, VVUS, HFC, HD, M, MSO, RSH, SKS, TSL, AWK, EIX, PCLN, FSLR, RRC, WFT, DLTR, JOY, SWC, TGT)

U.S. equity markets opened higher this morning and wobbled around before heading upward for most of the day. Strong home prices and a surge in the consumer confidence index (more ...
Read Full Story »
76764023

VIVUS Obesity Drug Sales Only About 60% of Expectations

VIVUS Inc. (NASDAQ: VVUS) reported a quarterly loss of $0.56 per share on Monday, but this was not an earnings story. VIVUS remains a developing story about its obesity drug ...
Read Full Story »
Bull and Bear figures

24/7 Wall St. Closing Bell — February 25, 2013: Markets Slide on Italian Elections (AIG, SWY, OXY, PAAS, VMW, DDD, FE, HL, HTZ, LOW, KWK, ADSK, OKE, TUMI, VVUS, AZO, BZ, HFC, HD, M, MSO, RSH, SKS, THC, TSL, DDD, AFFY, ZNGA)

U.S. equity markets opened higher this morning as they awaited results from the Italian elections. Early exit polls had the center-left party of Pier Luigi Bersani in the lead, but ...
Read Full Story »